Prevalence of peripheral artery disease in patients with infectious diabetic foot ulcer in Imam Reza Hospital in Kermanshah during 2019–2020

نویسندگان

1 School of Medicine, Kermanshah University of Medical Science, Kermanshah, Iran

2 Department of Neurology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

3

4

5

6 Department of Vascular and Endovascular Surgery, Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran,

7 Department of Biostatistics and Epidemiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah,

8

9

doi
چکیده

BACKGROUND: Diabetes mellitus (DM) is one of the main public health troubles diabetic footulcer (DFU) is one of the most important and relatively common causes of hospitalization. This studyinvestigates the prevalence of peripheral artery disease (PAD) in Imam Reza Hospital of Kermanshahduring 2017–2018.MATERIALS AND METHODS: This study is descriptive‑analytical. The study population was196 cases with infectious DFUs admitted to Imam Reza Hospital of Kermanshah during 2019–2020.The presence or absence of PAD was assessed in these cases. The collected data were analyzedby SPSS software (version 18.0).RESULTS: Among 196 patients studied, 120 (61.22%) patients had PAD. The prevalence ofPAD was higher in men than in women and it was more common in Type 2 DM patients than inType 1 DM patients. The majority of ulcers were located on the nonplantar surface of the foot.Moreover, the prevalence of PAD had a significant relationship by increasing the duration ofdiabetes (P = 0.041), history of amputation (P = 0.002), history of diabetic foot (P = 0.006), andperipheral neuropathy (P = 0.005).CONCLUSION: A considerable number of diabetic patients with DFU had PAD. This necessitatesmore intense interventions to manage PAD as a strong risk factor for DFU in diabetics. Neurovascularassessment of diabetic patients and early diagnosis of PAD may be appropriate interventions toprevent development of DFUs. We recommend trial studies to find out the best methods to addressearly detection of PAD in diabetics.